Markets
BAX

Baxter International (BAX) Q4 Earnings Beat, Sales Miss

Headquartered in Deerfield, Illinois, Baxter International Inc.BAX is a global medical products and services company. The company's Hospital Products business manufactures products used in the delivery of fluids and drugs to patients. Renal portfolio is mainly for patients with kidney failure/disease and their healthcare providers.

Currently, Baxter International has a Zacks Rank #3 (Hold) but that could change following its fourth quarter 2016 earnings report which has just released. (You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.) We have highlighted some of the key details from the just-released announcement below:

Earnings: Baxter's adjusted earnings of 57 cents per share beat the Zacks Consensus Estimate of 52 cents and increased by 14 cents from the year-ago quarter.

Revenues: Baxter posted sales of $2.64 billion, marginally missing the Zacks Consensus Estimate for revenues of $2.66 billion. At constant currency (cc), revenues increased 2% on a year-over-year basis.

Baxter International Inc. Price and EPS Surprise

Baxter International Inc. Price and EPS Surprise | Baxter International Inc. Quote

Key Stats : Hospital products sales increased 1% at cc, while renal products went up 5% from the year-ago quarter.

Major Factors : Hospital Products sales in the quarter were driven by solid demand for IV solutions, nutritional therapies, pharmacy injectables and IV access administration sets in the U.S. Renal products sales were driven by peritoneal dialysis products as well as increased demand globally for continuous renal replacement therapies.

Stock Price: Shares have risen 2.5% over the past 3 months, while the Zacks categorized Medical Products sub industry has gained roughly 1% over the same time frame.

Check back later for our full write up on this Baxter International report later!

Zacks' Top 10 Stocks for 2017

In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2017?

Who wouldn't? As of early December, the 2016 Top 10 produced 5 double-digit winners including oil and natural gas giant Pioneer Natural Resources which racked up a stellar +50% gain. The new list is painstakingly hand-picked from 4,400 companies covered by the Zacks Rank. Be among the very first to see it>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Baxter International Inc. (BAX): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

BAX

Other Topics

Earnings Investing Stocks

Latest Markets Videos